APPLICATION
ANDA206477
TYPE
ANDA
ORIGINAL APPROVAL
2016-06-24
LATEST ACTION
2023-01-17
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
DIAZEPAMPrescription
DIAZEPAM 5MG/5ML · SOLUTION · ORAL
Approval history
2023-01-17Labeling · Supplement 4 · standardAP
2021-02-05Labeling · Supplement 2 · standardAP
2016-06-24UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.